Novavax up; Shah Capital to vote against board, exec pay
Shares of vaccine maker Novavax NVAX.O rise 6.1% to $8.47 premarket
Activist investor Shah Capital plans to vote against the re-election of board nominees and the executive compensation package at Novavax's upcoming annual meeting
In a letter sent Wednesday, Shah Capital founder Himanshu Shah criticizes management for failing to implement aggressive cost-cutting measures
Investor urges company to slash expenses and opportunistically repurchase 10–20 mln shares
Shah Capital owns about 9% of Novavax, making it the company’s second-largest shareholder
Hedge fund has been pressing the board to pursue strategic alternatives, including a potential sale of the biotech firm
As of last close, stock up 18.8% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
SpaceX IPO Guide: Can You Buy SpaceX IPO Shares on Robinhood? How Can Investors in Asia and Europe Buy SpaceX IPO Shares?

Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

Amazon Stock: 4 Pillars Supporting a Buy Thesis in a Cautious Market

Tradingkey







